Announcements Trials
Browse Landscape

Phase

Phase 1/2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Breast Neoplasms 214Neoplasms 197Carcinoma, Non-Small-Cell Lung 91Colorectal Neoplasms 89Prostatic Neoplasms 78Lung Neoplasms 75Multiple Myeloma 49Head and Neck Neoplasms 47Melanoma 46Pancreatic Neoplasms 45Neoplasm Metastasis 44Leukemia, Myeloid, Acute 41Carcinoma, Hepatocellular 41Recurrence 37Brain Neoplasms 37Squamous Cell Carcinoma of Head and Neck 34Ovarian Neoplasms 32Glioblastoma 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Glioma 29Uterine Cervical Neoplasms 27Sarcoma 27Stomach Neoplasms 26Lymphoma, Non-Hodgkin 26Lymphoma 26Carcinoma, Renal Cell 26Motor Activity 24Lymphoma, Follicular 24Colonic Neoplasms 23Lymphoma, Large B-Cell, Diffuse 22

Interventions

Paclitaxel 1Oxaliplatin 1Irinotecan 1Injections 1Fluorouracil 1Docetaxel 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Advanced Malignant Tumors × 90 days × Clear all
NCT05235542 2026-06-11

A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors

Akeso

Phase 1/2 Completed
128 enrolled

Advanced Malignant Tumors

NCT05779163 2026-05-14

A Phase I/II Clinical Trial of LBL-033 in the Treatment of Advanced Malignant Tumors

Nanjing Leads Biolabs Co.,Ltd

Phase 1/2 Completed
26 enrolled

Advanced Malignant Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡